Jearanaiwitayakul, T., Seesen, M., Chawengkirttikul, R., Limthongkul, J., Apichirapokey, S., Sapsutthipas, S., . . . Ubol, S. (2021, July). Intranasal Administration of RBD Nanoparticles Confers Induction of Mucosal and Systemic Immunity against SARS-CoV-2. Vaccines.
Chicago Style (17th ed.) CitationJearanaiwitayakul, Tuksin, Mathurin Seesen, Runglawan Chawengkirttikul, Jitra Limthongkul, Suttikarn Apichirapokey, Sompong Sapsutthipas, Supaporn Phumiamorn, Panya Sunintaboon, and Sukathida Ubol. "Intranasal Administration of RBD Nanoparticles Confers Induction of Mucosal and Systemic Immunity Against SARS-CoV-2." Vaccines Jul. 2021.
MLA (9th ed.) CitationJearanaiwitayakul, Tuksin, et al. "Intranasal Administration of RBD Nanoparticles Confers Induction of Mucosal and Systemic Immunity Against SARS-CoV-2." Vaccines, Jul. 2021.
